Zavain Dar - Dec 7, 2021 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Zavain Dar
Stock symbol
RXRX
Transactions as of
Dec 7, 2021
Transactions value $
$0
Form type
4
Date filed
12/9/2021, 08:03 PM
Next filing
Jun 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A common stock Other $0 +3.6K $0.00 3.6K Dec 7, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro data distribution from Lux Ventures IV, L.P. and its affiliates, in a transaction which is exempt pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.